Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 13, 2025 09:30 ET | Source: Medigene AG

Medigene Files Patent for Unique NK-Specific TCR Construct with European Patent Office

Medigene AG (Medigene, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of cancer, today...
December 09, 2024 05:00 ET | Source: Medigene AG

Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell Engagers

Planegg/Martinsried, December 9, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...
October 24, 2024 01:30 ET | Source: Medigene AG

Medigene AG reports Financial Results and Business Update for Q3 2024

Planegg/Martinsried, October 24, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...
October 02, 2024 09:00 ET | Source: Medigene AG

Medigene will Present at ASGCT 2024 and Host R&D Event

Planegg/Martinsried, October 2, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...
September 14, 2024 07:30 ET | Source: Medigene AG

Medigene Presents Progress on KRAS Library and UniTope & TraCR Technology at ESMO 2024

Planegg/Martinsried, September 14, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...